Author Q&A: Hilary Wething on US Paid Sick Leave Policy Impacts
Wething’s research investigates the impact of state paid sick leave laws on influenza-like-illness rates.
Legal Research
-
Read more: Author Q&A: Hilary Wething on US Paid Sick Leave Policy Impacts -
Read more: New data: Baby-Friendly Hospital Laws New data: Baby-Friendly Hospital Laws
The Baby-Friendly Hospital Initiative (BFHI) is a global initiative of UNICEF and the World Health Organization aimed at promoting hospital policies that encourage and support breastfeeding. Baby-Friendly USA, the organization primarily responsibile for implementing BFHI in the United States, has outlined 10 evidence-based practices that hospitals can implement to support breastfeeding — called the 10…
-
Read more: New paper on cross-disciplinary collaboration New paper on cross-disciplinary collaboration
By Timo Minssen The nature of today’s most vital challenges and funding policies are driving more and more researchers towards interdisciplinary work. But what are the essential tools for those breaking the silos and leaving the comfort zones of their own disciplines? Some advice on how to address the particular challenges and opportunities in interdisciplinary research are described in our recent…
-
Read more: The Revival of Phage Therapy to Fight Antimicrobial Resistance (AMR) – Part III: What about patent protection and alternative incentives? The Revival of Phage Therapy to Fight Antimicrobial Resistance (AMR) – Part III: What about patent protection and alternative incentives?
By Timo Minssen In Part II of this blog on legal issues relating to the revival of phage therapy I discussed the US Supreme Court’s decisions in Myriad and Prometheus, which might present major obstacles to the patentability of phage-related technology (a more detailed analysis of the Myriad and Prometheus decisions is available here). Yet,…
-
Read more: The Revival of Phage Therapy to Fight Antimicrobial Resistance – Part II: What about patent protection and alternative incentives? The Revival of Phage Therapy to Fight Antimicrobial Resistance – Part II: What about patent protection and alternative incentives?
By Timo Minssen Three days ago I commented on a couple of legal issues raised in the recent Nature report “Phage therapy gets revitalized” by Sara Reardon. One challenge concerns the reluctance of pharma companies to broadly invest in the development of phage therapies. As pointed out in the report, this does of course very…
-
Read more: Happy Public Health Week: “We’re Good Enough, We’re Smart Enough, and Doggone It, People Like Us” Happy Public Health Week: “We’re Good Enough, We’re Smart Enough, and Doggone It, People Like Us”
By Scott Burris We may be living in a golden age of group-think. A weekly reminder is poor Paul Krugman railing against the apparently universal belief in America and Europe that we’ve got to cut budgets right now or disaster will strike. He calls this a Zombie idea, a false claim that has been falsified…
-
Read more: Flu Vaccine Mandates for Health Care Workers Flu Vaccine Mandates for Health Care Workers
According to officials, the worst of this year’s devastating flu season should be over in most parts of the country. But in early January, the flu had hit 47 of 50 states. According to the CDC, a total of 78 influenza-associated pediatric deaths have been reported. Throughout this terrible flu season, there’s been much talk…
-
Read more: NIH + NFL = PHLR NIH + NFL = PHLR
By Scott Burris, JD The National Football League has given the National Institutes of Health $30 million for research on traumatic brain injury. There is much we don’t know about the causes, effects, prevention and treatment of sports-related brain injury – but that doesn’t mean that we should put all our eggs into the basket…
-
Read more: Needing a Lawyer on the Team Needing a Lawyer on the Team
by Wendy Parmet It’s easy to see the value of including scientists in public health law research teams; most public health lawyers lack the training to conduct rigorous empirical research. It may be harder to see the need for adding lawyers to the research team, but their presence is no less critical. Sometimes scientists have…